|
ACCREDO’S HEMOPHILIA HEALTH SERVICES
At Accredo’s Hemophilia Health Services, a division of Accredo Health Group, Inc . , our goal is simple—to enhance the quality of life for those affected by bleeding disorders. Since 1990, Accredo’s Hemophilia Health Services has served the needs of patients, clinicians, and health plans with comprehensive therapy monitoring and support services designed to help:
- Prevent bleeds
- Minimize infusions
- Eliminate avoidable ER visits
- Decrease cost through assay management
- Improve satisfaction and quality of life
As one of the nation’s largest purchasers of clotting factor, Accredo’s Hemophilia Health Services has a comprehensive catalog of products—including all name-brand factor concentrates, in a complete range of assays. Along with clotting factor, Accredo’s Hemophilia Health Services also offers a full line of infusion devices and supplies.
CRITICAL CARE SYSTEMS
A wholly owned subsidiary of Accredo Health Group, Inc., Critical Care Systems, Inc., is a leading national specialty infusion provider offering services to pediatric and adult populations for the following specialty infusion therapies:
- Anti-infective therapy
- Total parenteral nutrition (TPN)
- Immunoglobulin therapy (IVIG)
- Inotropic therapy
- Hydration therapy
- Pain management
- Chemotherapy
Through its national footprint of community-based branch pharmacies, Critical Care Systems offers a cost-effective alternative to hospitalization, providing pharmaceutical products and comprehensive infusion services to patients in alternate site settings, such as the home or an ambulatory infusion suite.
Each branch pharmacy is accredited by the Joint Commission (formerly JCAHO) and has a local multidisciplinary team of experienced professionals who clinically manage all aspects of a patient's infusion and related support needs.
PROHERANT
Proherant Health, Inc. (Proherant), an affiliate company of Accredo Health Group, delivers a full spectrum of clinical and reimbursement support services to pharmaceutical, biotechnology, and medical device manufacturers throughout the research, pre-market, and post-market product commercialization phases. Proherant, formerly known as Clinical Business Solutions, has provided manufacturer support services for more than 20 years.
Organizationally, Proherant functions as a separate wholly owned subsidiary of Accredo Health, Inc., and benefits from the extensive resources of a large company, while still operating as a small manufacturer-centric entity. Proherant specializes in providing services associated with specialty drug products that have complex characteristics and requirements with uncompromising focus on patients.
To learn more about Proherant’s clinical support services, please visit www.proherant.com.
| 
